WAT$304.24

Waters Corporation demonstrates inconsistent growth, with revenue growth fluctuating from 17.78% in FY21 to near flat in FY23 and FY24, before recovering to 6.99% in FY25. Net income growth also shows volatility, with declines in FY23 and FY24. Gross margins are consistently strong, hovering around 58-59%, indicating efficient cost of revenue management. However, operating margins have compressed from 29.5% in FY21 to 25.36% in FY25, primarily due to rising operating expenses, particularly selling, general & administrative costs. There are no significant one-off items skewing earnings, suggesting the observed trends reflect structural shifts. Assuming Waters Corporation operates in the specialized laboratory equipment and software sector, these margins are respectable, but the declining operating margin is a concern. The primary risk is the sustained increase in total operating expenses outpacing revenue growth, leading to overall profitability erosion despite stable gross margins. This trend warrants close monitoring to assess if it's a short-term investment phase or a sustained pressure on operational efficiency.

Waters Corporation demonstrates a generally healthy balance sheet, though recent trends warrant attention. Total current assets have shown growth from $1,629 million in FY2021 to $2,148 million in FY2025, while total current liabilities also increased from $680.51 million to $1,239 million over the same period, suggesting some tightening of short-term liquidity, especially with the increase in short-term debt in FY2025. Total assets have expanded robustly from $3,095 million to $5,077 million. Total liabilities, while increasing from $2,727 million to $3,477 million by FY2023, have notably decreased to $2,515 million in FY2025, driven by a reduction in long-term debt. Shareholders' equity has shown consistent and strong growth, more than doubling from $367.55 million to $2,561 million, indicating improved solvency and asset quality. The significant increase in goodwill and other intangible assets from FY2022 to FY2023 indicates substantial acquisition activity. Overall, the company maintains a solid equity base and has improved its leverage profile recently.

Waters Corporation's operating cash flow (CFO) has shown some volatility, with growth ranging from -18.15% in FY 2022 to 26.43% in FY 2024. While capital expenditures have been consistently negative, indicating ongoing investment, they have also shown a decreasing trend, which is positive for FCF. Free cash flow (FCF) has been positive across all periods, reaching a high of $619.64 million in FY 2024, demonstrating consistent cash generation after capital reinvestment. FCF margin has also remained healthy, averaging around 17.7% over the last five years. However, significant swings in financing activities, including large debt issuances and repayments, alongside fluctuating share repurchases, suggest a dynamic capital allocation strategy that warrants continued monitoring. The large payment for business acquisitions in FY 2023 also impacted overall cash flow.

Waters Corporation demonstrates good financial health. Liquidity, as indicated by the current ratio, has slightly declined from 2.24 to 1.73 over the period, suggesting some reduction in short-term coverage, although still reasonable. Leverage has shown significant improvement, with the Debt/Equity ratio decreasing substantially from 3.24 to 0.57, indicating a stronger capital structure and reduced reliance on debt. Efficiency metrics like asset turnover have seen a decline from 0.93 to 0.68, suggesting a less productive use of assets over time, while inventory turnover has also decreased. Profitability and returns, particularly ROE and ROIC, have trended downwards from very high levels in 2022 (ROE 162.32%, ROIC 31.3%) to more moderate but still healthy levels (ROE 33.12%, ROIC 19.05% currently), reflecting a normalization rather than a severe deterioration.

Waters Corporation demonstrates a mixed growth profile, with a recent dip in 2023-2024 followed by a strong recovery projected from FY2025. Historical revenue growth was robust in FY2021 (17.78%) and FY2022 (6.68%) but turned negative in FY2023 (-0.52%) and remained flat in FY2024 (0.07%). However, analyst estimates project significant revenue acceleration, reaching 104.66% in FY2026 and 10.53% in FY2027. EPS growth shows a similar pattern of contraction in 2023-2024 but an expected rebound in 2026-2027, with 35.05% and 13.1% respectively, outpacing revenue in some periods, suggesting potential margin expansion. Forward P/E multiples of 20.94x for FY2026 and 18.51x for FY2027 appear reasonable given the substantial anticipated growth. Analyst sentiment is positive, with a 'Buy' consensus from 16 analysts, and the recommendation trend shows a slight improvement in 'Strong Buy' and 'Buy' ratings from Nov '25 to Mar '26, indicating increasing conviction.